跳至主要内容
临床试验/IRCT201702209662N12
IRCT201702209662N12已完成1 期

Impact of curcumin capsules on serum levels of pro-inflammatory,anti-inflammatory cytokines and cell adhesion molecules in Non-alcoholic fatty liver disease

Vice chancellor for research of Isfahan Cardiovascular Research Center0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Adult subjects with symptoms of metabolic syndrome including waist circumference greater than 102 cm (male) or greater than 88cm (female); blood pressure greater than or equal 130/ 85 mmHg; triglycerides greater than 150 mg/dl; high-density lipoprotein cholesterol (HDL-C) less than 40 mg/d (males) or less than 50 mg/d (females); and fasting blood glucose greater than 100 mg/dL were screened for eligibility. Also inclusion criteria were diagnosis of NAFLD (grades 1–3) according to liver ultrasonography.
  • Exclusion criteria: will be pregnancy or breastfeeding; NAFLD secondary to alcohol consumption; smoking, consumption of hypoglycemic; hypolipidemic; and anti-inflammatory medications as well as any drug known to affect hepatic function; and the presence of hepatitis; coronary; renal; pulmonary; and thyroid diseases

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Isfahan Cardiovascular Research Center

相似试验